Navigation Links
Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants
Date:1/28/2011

EMERYVILLE, Calif., Jan. 28, 2011 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the pricing of its previously announced underwritten public offering, to sell up to 30,031,200 units at a price per unit of $1.00 for aggregate gross proceeds of approximately $30 million.  Each unit consists of one share of common stock and a warrant to purchase one half of one share of Bionovo common stock at an exercise price of $1.30 per share.  The warrants may be exercised at any time after the date of the closing and will expire after five years.  The offering is expected to close on or about Wednesday, February 2, 2011, subject to customary closing conditions.

Bionovo expects to use the net proceeds from this offering to advance its lead drug candidate for postmenopausal vasomotor symptoms, Menerba, into Phase 3 clinical trials, and for general corporate purposes.

Cowen and Company, LLC, is acting as the sole bookrunner for the transaction. Bionovo granted the underwriter a 30-day option to arrange for the sale of up to 4,504,680 units to cover over-allotments. Lifetech Capital (a division of Aurora Capital) is acting as an advisor on the transaction.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. A registration statement relating to these securities has been filed with the Securities and Exchange Commission and is effective.  You may obtain these documents for free by visiting EDGAR on the SEC's website, at '/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014 Research and Markets ... the "Investment Analysis of the US Medical ... http://photos.prnewswire.com/prnh/20130307/600769 ... medical device sector identifies the key trends and ... investments, and mergers and acquisitions. The ...
(Date:12/22/2014)... , Dec. 22, 2014 Swedish Orphan ... today announced that the Committee for Medicinal Products for ... has adopted a positive opinion for the use of ... men with Peyronie,s disease with a palpable plaque and ... start of therapy. The use of Xiapex ...
(Date:12/22/2014)... 2014  Eiger BioPharmaceuticals Incorporated announced the positive ... in patients with chronic hepatitis delta virus (HDV) ... Institutes of Health (NIH) Clinical Center in ... placebo-controlled, dose ascending study evaluated two doses of ... twice daily for 28 days.  "This proof-of-concept study ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... Fla., Dec. 1, 2011  Hybrid Fuels, Inc. (Pink Sheets: ... acquired 100% of the shares of EMG Marketing Solutions, ... sales, marketing and product development expertise to the multi-billion ... a wholly owned subsidiary of Hybrid Fuels. ...
... 2011 HASCO Medical, Inc. (OTCBB: HASC), www.mysouthernmed.com ... serves patients in Alabama, Florida, and Mississippi, announced today ... Ocala, Florida. The acquisition closed on November 16, 2011. ... supplier that has been located in the Ocala, Florida ...
Cached Medicine Technology:Hybrid Fuels, Inc. Acquires Marketing Company Focused on Multi-Billion Dollar Nutraceutical/Pharmaceutical Industry 2HASCO Medical Announces Approval to Acquire Certified Medical and Certified Auto of Ocala 2HASCO Medical Announces Approval to Acquire Certified Medical and Certified Auto of Ocala 3
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – Forecast ... treatment landscape, unmet needs, current pipeline and commercial opportunities ... drug which is typically used for treating colorectal cancer. ... treating gastric cancer and pancreatic cancer. TS-1 is composed ... first approved in 1999 in Japan for the treatment ...
(Date:12/25/2014)... the popular online supplier of wedding dresses and special occasion ... black one-shoulder cocktail dresses . In addition, all these elegant ... prices, up to 70% off. , The development ... You know, we have thousands of frequent callers in the ... can visit our website for more details. The current special ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, ... discounts on all its wedding dresses. BellasDress has chosen ... more for gift choices for the holiday season. ... can pick suitable wedding gowns here at discount prices. ... shopping experience at its website. , “All ...
(Date:12/25/2014)... December 25, 2014 When head lice hits ... in a frenzy to get rid of it while keeping ... in Coral Gables now have the solution right in their ... clinic location, Lice Troopers provides full spectrum head lice screening ... Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, ...
(Date:12/25/2014)... News) -- The risk of burns from fires and ... to be extra cautious, an expert says. "Between ... increase in patients coming in with burns," said Dr. ... Firefighters Burn Center of Stony Brook University Hospital in ... joy, but if not careful, could quickly turn tragic," ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2
... disorder have slightly higher death rate, study shows , TUESDAY, ... celiac disease face a slightly higher risk of dying than ... disease were the main causes of death in the patients ... had small-intestinal biopsies in childhood, the researchers found. , Celiac ...
... , NEW YORK, Sept. 15 The U.S. ... as its newest board member. Brutto, who serves as president of ... development experience to the Fund, which serves as the primary fundraising ... , , A native of Chicago, Brutto oversees ...
... , NASHVILLE, Tenn., Sept. 15 Hospital Corporation ... the InformationWeek 500, which lists the nation,s most innovative users of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050825/CLTH069LOGO ) , , ... 2009 at an awards ceremony held during the InformationWeek 500 Conference ...
... Indiana University School of Medicine scientists have received ... the federal economic stimulus legislation, funding that has ... the medical center campus. More than 40 ... awards ranging from a $1.4 million National Science ...
... , , , SARASOTA Fla., Sept. ... 15th anniversary of helping seniors do more than they think they can ... a dreaded diagnosis or has a health crisis, family members often are ... Kobritz RN, head of Youthful Aging Home Health Care, the caregivers simply ...
... , BURBANK, Calif., Sept. 15 A ... and the Childrens Hospital Los Angeles Medical Group has been developed ... a group that nationwide falls in a gap between adult and ... The Adolescent & Young Adult Cancer Program is believed ...
Cached Medicine News:Health News:UPS Chief Named to U.S. Fund for UNICEF's Board of Directors 2Health News:Hospital Corporation of America Recognized by InformationWeek as One of Nation's Most Innovative Users of Business Technology 2Health News:Indiana U medical researchers boost research and jobs with stimulus legislation grants 2Health News:Indiana U medical researchers boost research and jobs with stimulus legislation grants 3Health News:Indiana U medical researchers boost research and jobs with stimulus legislation grants 4Health News:Seniors May Think They Can't, But They Can 2Health News:Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 2Health News:Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: